Intrathecal Pain Pump

Overview

An intrathecal pain pump is an implanted drug-delivery system that sends medication directly into the fluid around the spinal cord. This is called intrathecal drug delivery. The goal is to target pain pathways more directly than oral or intravenous medication, sometimes allowing lower systemic doses and fewer whole-body side effects.

Pain pumps are not first-line treatment. They are considered for carefully selected patients with severe pain that remains disabling despite a structured pain management plan. The goal is meaningful pain reduction, better comfort, improved function, or fewer medication side effects, not a guarantee of complete pain relief.

When it may be considered

Intrathecal pain pump therapy may be considered for selected patients with:

• Cancer-related pain that remains difficult to control with systemic medication
• Severe chronic pain that has not responded adequately to medication, injections, therapy, surgery, or neuromodulation
• Medication side effects that limit the ability to use effective systemic doses
• A pain pattern and overall medical situation where targeted drug delivery is more appropriate than another procedure

The decision is individualized. A pump may not be appropriate when pain is widespread without a clear treatment goal, when follow-up cannot be maintained, when infection risk is too high, or when another diagnosis or treatment should be addressed first.

How it works

The system includes a pump reservoir, refill port, programmable computer, and catheter. The pump is usually implanted under the skin of the abdomen. The catheter carries medication from the pump to the intrathecal space around the spinal cord.

Before implantation, many patients undergo a trial or test dose. The trial helps estimate whether intrathecal medication provides useful pain relief and whether side effects are acceptable. If the trial and overall evaluation support treatment, the pump and catheter are implanted surgically.

After implantation, the dose is adjusted over time. The pump must be refilled in clinic before the reservoir runs low, and the device must be monitored for alarms, catheter problems, infection, medication effects, and eventual battery replacement.

Pain pump vs other options

An intrathecal pain pump is different from spinal cord stimulation, DRG stimulation, peripheral nerve stimulation, or nerve surgery. Stimulation changes how pain signals are processed using electrical therapy. A pain pump delivers medication directly to the spinal fluid. Nerve surgery is considered when pain comes from a surgically treatable nerve problem.

These options can overlap in the same broad pain practice, but they are not interchangeable. The best option depends on the diagnosis, pain distribution, prior treatments, medical condition, medication tolerance, and the patient’s goals.

Risks and responsibilities

Possible risks include infection, bleeding, spinal fluid leak, catheter blockage or disconnection, pump malfunction, medication side effects, overdose, withdrawal if medication delivery stops, wound problems, and need for revision surgery. A pump also creates a long-term maintenance responsibility.

Patients and caregivers need to understand refill schedules, medication safety, pump alarms, travel planning, and when symptoms require urgent attention. Missing refills or ignoring pump alarms can be dangerous.

Dr. Barone’s approach

Dr. Barone evaluates intrathecal pain pump therapy as one option within a broader pain and neuromodulation strategy. The focus is on confirming that the pain problem, prior treatment history, medical condition, and long-term follow-up needs fit the therapy before implantation is considered.

When a pump is reasonable, the plan is built around a clear treatment goal: less severe pain, improved comfort, fewer systemic medication side effects, better sleep, easier care, or improved quality of life.